APTEVO THERAPEUTICS INC

Historical 13F Holders

Symbol
APVO
CUSIP
03835L504
All holders as of
Q3 2025
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 03835L504 since 12/18/2024, newest first.

Filer % of Class Filed
Point72 Asset Management, L.P. 13G/A Amendment 1
0% 2/17/2026
Event 12/31/2025
Bank of America Corp /DE/ 13G/A Amendment 1 0% 11/7/2025
Event 10/31/2025
Bank of America Corp /DE/ 13G 15.0% 10/6/2025
Event 9/30/2025
Point72 Asset Management, L.P. 13G
9.1% 9/17/2025
Event 9/16/2025
CVI Investments, Inc. 13G/A Amendment 1
9.9% 8/14/2025
Event 6/30/2025
L1 Capital Global Opportunities Master Fund, Ltd. 13G/A Amendment 1 4.99% 8/14/2025
Event 8/14/2025
YA II PN, Ltd. 13G
10.0% 7/8/2025
Event 6/16/2025
L1 Capital Global Opportunities Master Fund, Ltd. 13G 10.0% 6/23/2025
Event 6/18/2025
L1 Capital Global Opportunities Master Fund, Ltd. 13G/A Amendment 1 0.7% 6/23/2025
Event 4/26/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 12 494 k $717 k
2025 Q2 7 5.04 k $15.4 k